Episode 171 - January 30, 2026

The Biotech Hangout podcast features a panel discussion with John Crowley, President and CEO of Bio, focusing on the competition between the U.S. and China in the biotech industry. Crowley emphasizes the importance of biotech for public health, economic growth, and national security, advocating for the U.S. to out-compete rather than out-China China by modernizing the FDA and reforming clinical trials. The conversation explores strategies for the U.S. to maintain its lead in biotech innovation and ensure global access to medicines, addressing systemic barriers like insurance inconsistencies and out-of-pocket costs. The panel also discusses the measles outbreak, vaccine hesitancy, and policy issues like MFN and tariffs, highlighting the need for the U.S. to remain competitive.